Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.16 USD | +1.44% | -2.76% | -7.10% |
May. 24 | Recursion Names HilleVax CEO Robert Hershberg as New Board Chair | MT |
May. 24 | Recursion Pharmaceuticals, Inc. Announces Chair of the Board Changes | CI |
Financials (USD)
Sales 2024 * | 58.86M | Sales 2025 * | 63.02M | Capitalization | 2.18B |
---|---|---|---|---|---|
Net income 2024 * | -401M | Net income 2025 * | -472M | EV / Sales 2024 * | 30.9 x |
Net cash position 2024 * | 358M | Net cash position 2025 * | 336M | EV / Sales 2025 * | 29.2 x |
P/E ratio 2024 * |
-5.57
x | P/E ratio 2025 * |
-5.03
x | Employees | 500 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.87% |
1 day | +1.44% | ||
1 week | -2.76% | ||
Current month | +17.14% | ||
1 month | +15.37% | ||
3 months | -31.49% | ||
6 months | +33.53% | ||
Current year | -7.10% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 41 | 13-11-04 | |
Blake Borgeson
FOU | Founder | 42 | 13-11-04 |
Dean Li
FOU | Founder | 62 | 13-11-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Hershberg
BRD | Director/Board Member | 61 | 20-03-19 |
Chairman | 60 | 20-03-31 | |
Dean Li
FOU | Founder | 62 | 13-11-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.51% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 9.16 | +1.44% | 3,414,274 |
24-05-23 | 9.03 | -3.53% | 6,738,940 |
24-05-22 | 9.36 | -1.58% | 3,605,220 |
24-05-21 | 9.51 | -2.76% | 3,026,433 |
24-05-20 | 9.78 | +3.82% | 3,494,664 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.10% | 2.18B | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- RXRX Stock